Inhalation Sciences: First patient enrolled in clinical trial of PreciseInhale
(Stockholm, Sweden, June 16, 2021) The first patient has been enrolled, on schedule, in ISAB’s clinical trial of its aerosol generating system PreciseInhale[®]. CEO Manoush Masarrat: “Clinical validation of PreciseInhale[®] would be transformational for ISAB, opening up new markets and new opportunities for major growth.”On Wednesday 16 June, the first 4 healthy volunteer patients enrolled on the landmark clinical trial of PreciseInhale[®]. In total 12 patients will take part. The study aims to be finalized before the end of 2021. The study is being run by Clinical Trial Consultants AB (CTC)